J Neurol Surg A Cent Eur Neurosurg 2019; 80(02): 127-130
DOI: 10.1055/s-0038-1669471
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Contiguous Metastasis of Pulmonary Adenocarcinoma to Meningioma

Masato Nakaya
1   Department of Neurosurgery, Shizuoka City Shimizu Hospital, Shizuoka, Shimizu, Japan
,
Shinya Ichimura
1   Department of Neurosurgery, Shizuoka City Shimizu Hospital, Shizuoka, Shimizu, Japan
,
Yutaka Kurebayashi
2   Department of Clinical Pathology, Shizuoka City Shimizu Hospital, Shizuoka, Shimizu, Japan
,
Youichi Mochizuki
1   Department of Neurosurgery, Shizuoka City Shimizu Hospital, Shizuoka, Shimizu, Japan
,
Raita Fukaya
1   Department of Neurosurgery, Shizuoka City Shimizu Hospital, Shizuoka, Shimizu, Japan
,
Masahito Fukuchi
1   Department of Neurosurgery, Shizuoka City Shimizu Hospital, Shizuoka, Shimizu, Japan
,
Koji Fujii
1   Department of Neurosurgery, Shizuoka City Shimizu Hospital, Shizuoka, Shimizu, Japan
› Author Affiliations
Further Information

Publication History

20 March 2018

03 May 2018

Publication Date:
15 October 2018 (online)

Abstract

Background Metastasis from one tumor into another is known as tumor-to-tumor metastasis. We report a case of a contiguous occurrence of meningioma and brain cancer metastasis.

Patient A 91-year-old woman presented with a sudden onset of weakness in her right limbs and gait disturbance. Fourteen years previously, she had a tumor that was suspected to be a meningioma in the left frontal convexity with no change for several years. One year earlier to presentation she was diagnosed with lung carcinoma in the left lower lobe.

Results Magnetic resonance images revealed enlargement of the tumor with perifocal edema. Histologic examination showed a meningioma with contiguous metastatic poorly differentiated adenocarcinoma, as well as a clearly defined border between the two components. The clinical origin of the metastasis was presumed to be from the left lower lobe of the lung.

Conclusion Although our case does not strictly fulfill the definition of tumor-to-tumor metastasis, we suggest a contiguous occurrence develops by the same mechanism and may be a subtype of this process. Although previous reports suggested the loss of epithelial cadherin (E-cadherin) expression in the recipient tumor as the cause of contiguous metastasis, E-cadherin expression was positive in our case and did not seem to be involved in the localization of the metastasis.

 
  • References

  • 1 Seckin H, Yigitkanli K, Ilhan O, Han U, Bavbek M. Breast carcinoma metastasis and meningioma. A case report. Surg Neurol 2006; 66 (03) 324-327 ; discussion 327
  • 2 Xinyu H, Ye L, Wenchen L. , et al. Lung carcinoma dural metastasis and meningioma mimicking bilateral falcine meningiomas. Neurosurg Q 2015; 25 (04) 458-460
  • 3 Fried BM. Metastatic inoculation of a meningioma by cancer cells from a bronchiogenic carcinoma. Am J Pathol 1930; 6 (01) 47-52 .1
  • 4 Campbell Jr LV, Gilbert E, Chamberlain Jr CR, Watne AL. Metastases of cancer to cancer. Cancer 1968; 22 (03) 635-643
  • 5 Sayegh ET, Burch EA, Henderson GA, Oh T, Bloch O, Parsa AT. Tumor-to-tumor metastasis: breast carcinoma to meningioma. J Clin Neurosci 2015; 22 (02) 268-274
  • 6 Chambers PW, Davis RL, Blanding JD, Buck FS. Metastases to primary intracranial meningiomas and neurilemomas. Arch Pathol Lab Med 1980; 104 (07) 350-354
  • 7 Han HS, Kim EY, Han JY, Kim YB, Hwang TS, Chu YC. Metastatic renal cell carcinoma in a meningioma: a case report. J Korean Med Sci 2000; 15 (05) 593-597
  • 8 Moody P, Murtagh K, Piduru S, Brem S, Murtagh R, Rojiani AM. Tumor-to-tumor metastasis: pathology and neuroimaging considerations. Int J Clin Exp Pathol 2012; 5 (04) 367-373
  • 9 Chatani M, Nakagawa I, Yamada S. , et al. Intracranial meningioma as initial clinical manifestation of occult lung carcinoma: case report. Neurol Med Chir (Tokyo) 2014; 54 (08) 670-672
  • 10 Yoda J, Hirohashi Y, Yamanaka N. Implication of E-cadherin in metastasis of head and neck cancer. Jpn J Head Neck Cancer 1996; 22 (03) 471-475
  • 11 Mrachek EK, Davis D, Kleinschmidt-DeMasters BK. Dual use of E-cadherin and D2-40 immunostaining in unusual meningioma subtypes. Am J Clin Pathol 2015; 144 (06) 923-934
  • 12 Shimada S, Ishizawa K, Hirose T. Expression of E-cadherin and catenins in meningioma: ubiquitous expression and its irrelevance to malignancy. Pathol Int 2005; 55 (01) 1-7
  • 13 Nagaishi M, Nobusawa S, Tanaka Y, Ikota H, Yokoo H, Nakazato Y. Slug, twist, and E-cadherin as immunohistochemical biomarkers in meningeal tumors. PLoS One 2012; 7 (09) e46053
  • 14 Utsuki S, Oka H, Sato Y. , et al. Invasive meningioma is associated with a low expression of E-cadherin and beta-catenin. Clin Neuropathol 2005; 24 (01) 8-12
  • 15 Zhou K, Wang G, Wang Y, Jin H, Yang S, Liu C. The potential involvement of E-cadherin and β-catenins in meningioma. PLoS One 2010; 5 (06) e11231